International law firm Clifford Chance has advised Amdipharm Mercury (AMCo) on its acquisition of Australian pharmaceutical company, Boucher and Muir (BNM).
The acquisition of BNM is in line with AMCo’s strategy of international expansion into key territories. In addition to owning rights to a portfolio of specialty and niche medicines, B&M is one of AMCo’s distributors in Australia, New Zealand and the Pacific Islands.
The cross-jurisdictional Clifford Chance team comprised of lawyers from the UK and Australia. The team advising AMCo was led by partner Jonny Myers, with support from senior associate Christopher Sullivan and associates Angharad Lewis, Jonathan Halliwell and Oliver Jarvis-Bicknell from Sydney and London.
Clifford Chance has advised AMCo on a number of acquisitions to support the company to meet its expansion strategy, including its successful acquisition of Sweden-based Abcur AB in 2013.